amikacin has been researched along with Atypical Mycobacterial Infection, Disseminated in 198 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (9.60) | 18.7374 |
1990's | 28 (14.14) | 18.2507 |
2000's | 34 (17.17) | 29.6817 |
2010's | 67 (33.84) | 24.3611 |
2020's | 50 (25.25) | 2.80 |
Authors | Studies |
---|---|
Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J | 1 |
Byrd, TF; Greendyke, R | 1 |
Alcaraz, M; Illouz, M; Kremer, L; Roquet-Banères, F | 1 |
Kho, BG; Kim, TO; Kim, YI; Kwon, YS; Lee, JK; Lim, SC; Na, YO; Oh, HJ; Park, HK; Park, HY; Shin, HJ | 1 |
Akkerman, OW; Aliberti, S; Altenburg, J; Arets, B; Chiron, R; Delaere, B; Essink, S; Gohy, S; Haarman, E; Henriette Zweijpfenning, SM; Hoefsloot, W; Lorent, N; McKew, G; Morgan, L; Schildkraut, J; van Braeckel, E; van Ingen, J; Wagner, D | 1 |
Ciciriello, F; Cirillo, DM; D'Andrea, MM; De Santis, F; Fraziano, M; Henrici De Angelis, L; Lorè, NI; Lucidi, V; Olimpieri, T; Poerio, N; Riva, C; Rossi, M | 1 |
Jhun, BW; Jo, KW; Kang, YA; Kwak, N; Park, J; Park, SY; Park, Y; Park, YE; Shim, TS; Yim, JJ | 1 |
Li, H; Li, S; Mulati, G; Pang, Y; Ren, W; Shang, Y; Wang, Y; Xue, Z; Yao, C | 1 |
Daneshfar, S; Hashemzadeh, M; Khosravi, AD | 1 |
Chhaya, N; Koo, EH; Miller, D; Shaik, N; Tonk, RS; Weiss, M; Zhu, A | 1 |
Blouquit-Laye, S; Desquesnes, A; Girard-Misguich, F; Herrmann, JL; Le Moigne, V | 1 |
Chen, T; Huang, J; Li, L; Peng, S; Wang, J; Zhong, K | 1 |
Ahmad, MN; Chopra, S; Dasgupta, A; Garg, T; Kaur, P; Krishnamurthy, RV; Malik, P; Shukla, R; Singh, S | 1 |
Dirgahayu, P; Nuryastuti, T; Primaningtyas, W; Probandari, A; Saptawati, L; Suryawati, B; Sutanto, YS; Wasita, B | 1 |
Daley, CL; de-Moura, VC; Eddy, JJ; Hunkins, JJ; Khare, R | 1 |
D'Eletto, M; De Maio, F; Delogu, G; Goletti, D; Occhigrossi, L; Paglione, F; Palucci, I; Pereyra Boza, MDC; Piacentini, M; Rossin, F; Sali, M; Salustri, A; Sanguinetti, M | 1 |
Alcaide, F; Andres, S; Aubry, A; Benmansour, H; Boarbi, S; Cambau, E; Chryssanthou, E; Cirillo, DM; Fernström, L; Fitzgibbon, MM; Fröberg, G; Giske, CG; Hyyryläinen, HL; Kahlmeter, G; Keller, PM; Machado, D; Maurer, FP; Mengshoel, AT; Mok, S; Nadarajan, D; Schön, T; Svensson, E; Turnidge, J; van Ingen, J; Viveiros, M; Werngren, J | 1 |
Abe, Y; Akira, S; Fukui, E; Fukushima, K; Kida, H; Kitada, S; Komukai, S; Kumanogoh, A; Matsuki, T; Matsumoto, Y; Miki, K; Motooka, D; Nabeshima, H; Nagahama, Y; Nakamura, S; Nii, T; Niitsu, T; Nitta, T; Saito, H; Tsujino, K; Yamuchi, J | 1 |
Berude, J; Campbell-Kruger, N; Fetterman, R; Gonzalez Camba, J; Rodriguez, R; Stanley, S | 1 |
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA | 1 |
Ashizawa, N; Hirayama, T; Hosogaya, N; Ide, S; Ito, Y; Iwanaga, N; Izumikawa, K; Kido, T; Mukae, H; Obase, Y; Okano, S; Ozasa, M; Sakamoto, N; Takao, D; Takazono, T; Takeda, K; Takemoto, S; Tashiro, M; Yanagihara, K | 1 |
Aldridge, BB; Degefu, YN; Klickstein, J; Larkins-Ford, J; Leus, PA; Maurer, FP; Poonawala, H; Smith, TC; Stone, D; Thorpe, CM; Van, N | 1 |
Abad, L; Aull, HA; Cristinziano, M; Dedrick, RM; Hatfull, GF; Kaganovsky, AM; Loebinger, MR; Morkowska, A; Murthy, S; Satta, G; Smith, BE; Storey, N | 1 |
Brown-Elliott, BA; Brunton, AE; Fuss, C; Griffith, DE; Philley, JV; Siegel, SAR; Strnad, L; Sullivan, PE; Wallace, RJ; Winthrop, KL | 1 |
Dai, Y; Dai, ZQ; Li, L; Shi, YL; Yu, JY | 1 |
Baldovino Chiquillo, L; Leal, DD; Rico, DL; Romero, M | 1 |
Faksri, K; Oudomying, N; Payungporn, S; Petsong, S; Prommi, A; Rotcheewaphan, S; Suankratay, C; Sukmongkolchai, S; Suwanpimolkul, G; Usawakidwiree, W; Wongjarit, K | 1 |
Akiyama, Y; Horai, T; Iwamoto, N; Kamada, K; Mitarai, S; Nagashima, M; Ohmagari, N; Osugi, A; Suzuki, T; Yamamoto, K; Yoshida, A | 1 |
Calado Nogueira de Moura, V; Daley, CL; Hunkins, JJ; Khare, R; Nguyen, MH | 1 |
Jevert-Eichorn, S; Radigan, A | 1 |
Cohen, KA; Richter, WJ | 1 |
Del Parigi, A; Swenson, C | 1 |
Shulha, J | 1 |
Carrasco-Antón, N; Esteban, J; Muñoz-Egea, MC | 1 |
Erber, J; Rothe, K; Schmid, RM; Schneider, J; Spinner, CD; Tschaikowsky, T; Weidlich, S | 1 |
Chaudary, N; Khan, O | 1 |
Dash, A; Gupta, N; Kodan, P; Ray, Y; Singh, BK; Soneja, M | 1 |
Bañuls, AL; Bemer, P; Bertolotti, T; Bouzinbi, N; Chiron, R; Fangous, MS; Godreuil, S; Guet-Revillet, H; Héry-Arnaud, G; Marcy, O; Ouedraogo, AS; Pestel-Caron, M; Peuchant, O | 1 |
Chonan, M; Fujimoto, Y; Ihara, H; Iwai, M; Kurokawa, K; Misawa, S; Nakamura, A; Ochi, Y; Ohsaka, A; Okabe, T; Shibayama, K; Sumiyoshi, I; Takahashi, K; Takei, S; Togo, S; Watanabe, J | 1 |
Bonet-Rossinyol, Q; Fernández-Pittol, M; Gonzalez-Martin, J; López-Gavín, A; Portell-Buj, E; Roman, A; Tudó, G | 1 |
Dominic, C; Gill, LI; Tiberi, S | 1 |
Appavu, SP; Gunasekaran, R; Namperumalsamy Venkatesh, P; Naveen, R; Neha, P; Prajna, L; Rajapandian, SGK | 1 |
Daley, CL; Huh, HJ; Jeon, K; Jhun, BW; Kang, N; Kim, H; Koh, WJ; Kwon, OJ; Lee, NY | 1 |
Aljishi, A; Alwazzeh, MJ; Kristjansson, M | 1 |
Khandelwal, S; Malhotra, B; Sharma, M | 1 |
Bell, SC; Bordin, A; Clark, JE; Coulter, C; Hackett, H; Jennison, AV; Nimmo, GR; Pandey, S; Pardo, C; Syrmis, M; Wainwright, CE; Whiley, DM | 1 |
Bartolomeo, K; Hassanein, M; Vachharajani, TJ | 1 |
Aslan, AT; Deniz, M; Ramaslı Gursoy, T; Tapısız, A; Tezer, H | 1 |
Arai, Y; Iguchi, S; Kamada, K; Kikuchi, K; Konno, S; Shimojima, M; Uzawa, Y; Yoshida, A | 1 |
Daley, CL; Griffith, DE | 1 |
Gu, KM; Kim, JY; Kwak, N; Park, J; Yim, JJ; Yoon, SH | 1 |
Garner, OB; Mirasol, R; Realegeno, S; Yang, S | 1 |
Choi, JE; Jeon, K; Jhun, BW; Kim, DH; Kim, SY; Ko, JY; Koh, WJ; Lee, H; Lee, SY; Moon, IJ; Park, HJ; Park, HY; Shin, SJ; Sohn, YM | 1 |
Brown, K; Eagle, G; Floto, RA | 1 |
Asakura, T; Asami, T; Betsuyaku, T; Fujiwara, H; Funatsu, Y; Hasegawa, N; Iketani, O; Ishii, M; Kamo, T; Namkoong, H; Nishimura, T; Sugiura, H; Suzuki, S; Tasaka, S; Uwamino, Y; Yagi, K; Yamada, Y | 1 |
Burian, J; Kuchinski, K; Pryjma, M; Thompson, CJ | 1 |
Chopra, S; Das, S; Dasgupta, A; Karaulia, P; Pandey, AK; Pandey, M; Singh, AK; Soni, I; Thakare, R | 1 |
Lu, J; Pang, Y; Song, Y; Zhang, Z | 1 |
Chen, NY; Chiu, CH; Chung, WH; Kuo, AJ; Lai, HC; Lee, MC; Liu, TP; Lu, JJ; Sun, PL; Wang, LH; Wu, TL; Wu, TS; Yang, CH; Yang, JH | 1 |
Brenciani, A; Cellini, L; Cimarelli, ME; Di Giulio, M; Di Lodovico, S; Facinelli, B; Magi, G; Marini, E; Nostro, A | 1 |
Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
Barkan, D; Grosfeld, T; Meir, M | 1 |
Aguilar-Ayala, DA; Cnockaert, M; Gonzalez-Y-Merchand, J; Martin, A; Palomino, JC; Vandamme, P | 1 |
Kadiri, NP; Mannelli, VK; Nemakayala, DR; Rai, MP | 1 |
Allyn, J; Andre, M; Belmonte, O; Coolen-Allou, N; Gazaille, V; Payet, A; Picot, S; Touron, T; Veziris, N | 1 |
Baba, S; Fukuoka, K; Horikoshi, Y; Kamada, K; Kanemaru, A; Kikuchi, K; Myojin, S; Okamoto, Y; Suzuki, H; Yoshida, A | 1 |
Cai, SCS; Chan, W; Ling, KL; Low, JGH; Shim, HH; Tan, HH | 1 |
Chen, WL; Chu, HS; Hu, FR; Liu, HY; Wang, IJ | 1 |
Liu, D; Lu, J; Ni, X; Song, Y; Wang, S; Zhao, Y; Zheng, H | 1 |
Ananta, P; Chaimanee, P; Chetchotisakd, P; Faksri, K; Kham-Ngam, I; Lulitanond, V; Namwat, W; Reechaipichitkul, W | 1 |
Andersen, ÅB; Gynthersen, R; Katzenstein, TL; Qvist, T | 1 |
Chen, CL; Chen, CY; Chen, PL; Hsu, SM; Huang, FC; Hung, JH; Jou-Chen Huang, E; Ko, WC; Lai, CC; Lai, CH; Lin, SH; Teng, YT; Tseng, SH; Wang, SH; Wu, CL | 1 |
Laughon, BE; Lee, SFK; Lipman, M; McHugh, TD | 1 |
Dalcolmo, MP; Daley, CL; Eather, G; Gayoso, R; Hasegawa, N; Jhun, BW; Koh, WJ; Kwak, N; Namkoong, H; Park, J; Thomson, R; van Ingen, J; Yim, JJ; Zweijpfenning, SMH | 1 |
Bhimani, AD; Esfahani, DR; Haddadin, DW; Hu, K; Mehta, AI; Neisewander, BL; Shah, HP; Zakrzewski, J | 1 |
Aznar, ML; Brode, SK; Elshal, AS; Marras, TK; Mehrabi, M | 1 |
Costa, AFP; Farias Filho, FT; Laudelino, JS; Santos, VM | 1 |
Bostan, C; Boutin, T; Brunette, I; Choremis, J; Mabon, M; Slim, E; Talajic, JC | 1 |
Alsarraf, HMAB; Blaise, M; Kremer, L; Olieric, V; Ung, KL | 1 |
Carter, ER; Iwanaga, K | 1 |
Mittal, R; Padhy, TR; Rao, A; Sharma, S; Wallang, B | 1 |
Hu, ST; Lai, HC; Liau, JR; Lin, CH; Shen, GH; Tsai, SH | 1 |
Banerjee, P; Dogra, V; Haider, M; Husain, J; Jaggi, T; Loomba, P; Mishra, B; Thakur, A | 1 |
Gui, J; Hong, CY; Li, JL; Liang, J; Wang, F | 1 |
Bhattacharyya, D; Brewer, CC; Fleshner, M; Folio, LR; Glaser, TS; Holland, SM; Olivier, KN; Park, IK; Prevots, DR; Sampaio, EP; Shallom, S; Shaw, PA; Siegelman, JR; Zalewski, CK; Zelazny, AM | 1 |
Chang, TC; Huang, FC; Huang, YH; Hung, JH; Shih, MH; Tseng, SH; Wu, JJ | 1 |
Gotoh, M; Katagiri, S; Nakamura, I; Ohyashiki, K; Yoshizawa, S | 1 |
Fowler, J; Mahlen, SD | 1 |
Bermudez, LE; Gupta, R; Neville, ME; Rose, SJ | 1 |
Benwill, JL; Wallace, RJ | 1 |
Chang, SC; Chu, HS; Hu, FR; Shen, EP | 1 |
Baqai, J; Hong, AR; Huang, AJ; Lubniewski, AJ; Nguyen, AT | 1 |
Bender, WS; Egan, JP; Mukherjee, V | 1 |
Hashiguchi, N; Inoshima, I; Inoshima, N | 1 |
Cengiz, AB; Emiralioğlu, N; Ersöz, DD; Kiper, N; Oğuz, B; Özçelik, U; Özsürekçi, Y; Saribas, Z; Yalçın, E | 1 |
Daley, CL; Huh, HJ; Jeon, K; Jeong, BH; Ki, CS; Kim, CK; Kim, H; Kim, SY; Koh, WJ; Kwon, OJ; Lee, NY; Lee, SH; Park, HY; Park, KU; Shin, SJ | 1 |
Shah, VA; Siatkowski, RL; Sluch, IM | 1 |
Burillo-Martínez, S; Garrido-Ruiz, MC; Maroñas-Jiménez, L; Morales, E; Rodríguez-Peralto, JL | 1 |
Deshpande, D; Ferro, BE; Gumbo, T; Mouton, JW; Pasipanodya, JG; Srivastava, S; van Ingen, J; van Soolingen, D | 1 |
Asakura, T; Betsuyaku, T; Fujiwara, H; Hasegawa, N; Hoshino, Y; Ishii, M; Kurashima, A; Kurosaki, A; Morimoto, K; Namkoong, H; Nishimura, T; Sugiura, H; Suzuki, S; Tanaka, H; Tasaka, S; Yagi, K; Yamada, Y | 1 |
Addrizzo-Harris, DJ; Brown-Elliott, BA; Daley, CL; Dorgan, D; Eagle, G; Flume, PA; Griffith, DE; Gupta, R; Liu, K; McGinnis, JP; Micioni, L; Olivier, KN; Ruoss, S; Salathe, M; Wallace, RJ; Winthrop, KL | 1 |
Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK | 1 |
Chen, JH; Hu, ST; Lin, CF; Shen, GH; Wu, BD; Wu, KM | 1 |
Gutiérrez-de la Peña, J; Martín-Santiago, A; Montis-Suau, A; Ruiz-Veramendi, M | 1 |
Chang, KM; Chu, SH; Lee, HC; Shyur, SD; Wu, YL | 1 |
Pacheco, PA; Tam, PM | 1 |
Antony, VB; Bellew, BF; Brown, S; Faruqi, I; Mohammed, KA; Montes-Worboys, A; Moudgil, B; Regev, D; Sharma, P | 1 |
Huang, FC; Shih, MH | 1 |
Daley, CL; Huitt, GA; Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK; Shin, SJ | 1 |
Huang, YC; Kao, CC; Lin, CF; Liu, MF; Liu, PY; Shen, GH; Shi, ZY | 1 |
Bonne, S; Legout, L; Prevotat, A; Senneville, E; Veziris, N; Yazdanpanah, Y | 1 |
Atassi, K; Bassinet, L; Honoré, I; Housset, B; Jabot, L; Maître, B; Mangiapan, G; Monnet, I; Schubel, K | 1 |
Abbasi, S; Ikram, A; Khalid, MM; Manzar, MA; Sattar, A; Satti, L | 1 |
Girgis, DO; Karp, CL; Miller, D | 1 |
Bai, X; Chan, ED; Kartalija, M; Ovrutsky, AR | 1 |
Safdar, A | 1 |
Ankomah, P; Levin, BR | 1 |
Bensira, L; Domany, KA; Glatstein, M; Scolnik, D; Shah, M; Vala, S | 1 |
Borole, AJ; Chilgar, RM; D'Silva, JA; Thomas, M | 1 |
Huang, Y; Jiang, Y; Liu, P; Liu, Y; Sun, J; Wang, H; Wu, K; Xu, X; Zeng, X; Zhang, W | 1 |
Chen, JH; Hu, ST; Huang, CC; Huang, CW; Huang, WC; Lee, YC; Shen, GH | 1 |
Bentoucha, A; Dega, H; Grosset, J; Jarlier, V; Robert, J | 1 |
Doughman, DJ; Malecha, MA | 1 |
Dailloux, M; Dauendorffer, JN; Laurain, C; Weber, M | 1 |
Daines, BS; Sandoval, HP; Solomon, KD; Steed, LL; Vroman, DT | 1 |
Forslöw, U; Geborek, A; Heurlin, N; Hjelte, L; Petrini, B | 1 |
Baba, T; Ikehara, K; Ishigatsubo, Y; Kaneko, T; Kusano, N; Nishiyama, H; Shinohara, T; Shoji, A; Suzuki, S; Tagawa, A; Tsuburai, T | 1 |
Carbonnelle, B; Honoré, N; Kouakou, H; Legras, P; Manceau, AL; Marsollier, L; Payan, C; Prévot, G | 1 |
Li, GX; Lian, CH; Lin, Z; Liu, SX; Weng, KR; Wu, RS; Wu, WH | 1 |
Dick, JD; Hose, S; Hyon, JY; Joo, MJ; O'Brien, TP; Sinha, D | 1 |
Kasai, S; Nishiyama, H; Tokuda, H; Yoshikawa, M | 1 |
Cohen, EJ; Mah-Sadorra, JH; Rapuano, CJ | 1 |
Chen, YF; Hsiao, CH; Lin, KK; Yang, KS | 1 |
Bottone, EJ; Cho, KW | 1 |
Bar, T; Lewkowicz, A; Mishal, J; Nahlieli, O | 1 |
Chang, YL; Chen, JS; Hsu, HH; Hsueh, PR; Lee, YC | 1 |
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
Embil, JM; Rendina, A; Turner, R; Vinh, DC | 1 |
Kim, WJ; Oh, CH; Ryu, HJ; Song, HJ | 1 |
Birkness, KA; Dezzutti, CS; Guenthner, PC; Lal, RB; Quinn, FD; Swords, WE | 1 |
Haddad, R; Hamam, RN; Khoury, JM; Noureddin, B; Salti, HI | 1 |
Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J; Truffot, C | 1 |
De Freitas, D; Hofling-Lima, AL; Matieli, LC; Moraes, NS; Sampaio, J; Yu, MC | 1 |
Kamio, Y; Kimura, S; Kuriu, K; Nakajima, H; Shibuya, Y; Shikama, Y | 1 |
Espandar, L; Meyer, JJ; Moshirfar, M | 1 |
Fujii, H; Goto, H; Ikezawa, Z; Inayama, Y; Ito, S; Kajiwara, R; Kuroki, F; Shigehira, Y; Taniguchi, A; Yanagimachi, M; Yokosuka, T; Yokota, S | 1 |
Carpenter, JL; Troxell, M; Wallace, RJ | 1 |
Carter, MJ; Hull, DS; Mirate, DJ; Steel, JH | 1 |
Fudenberg, HH; Harley, RA; John, JF; Metcalf, JF; Wilson, GB | 1 |
Friedlaender, MH; Meisler, DM; Okumoto, M | 1 |
Malow, JB; Toranto, IR | 1 |
Crosson, FJ; Kaplan, EN; Lesesne, CB; Pearl, RM; Yeager, AS | 1 |
Ferrieri, P; Johnson, DE; Mitchell, C; Munson, D; Speert, DP; Thompson, TR; Wannamaker, LW | 1 |
Brink, AJ; Koornhof, HJ; Widgerow, AD | 1 |
Barrett, MS; Erwin, ME; Jones, RN; Koontz, FP | 1 |
Brewer, LV; Hussain, Z; Probst, LE; Tokarewicz, AC | 1 |
Ahn, CH; Brown, BA; Dunbar, D; Dunlap, R; Murphy, DT; Onyi, G; Wallace, RJ | 1 |
Berlin, OG; Bruckner, DA; Helm, CJ; Holland, GN; Lin, R | 1 |
Lee, BL; Matoba, AY; Osato, MS; Penland, R; Robinson, NM | 1 |
Biswell, R; Hwang, DG | 1 |
Cherubin, CE; Idemyor, V | 1 |
Armstrong, D; Boone, N; Brown, AE; Kiehn, TE; Polsky, B; Pursell, KJ; Tsivitis, M; White, M | 1 |
Chan, CY; Cheng, AF; Li, MS; Tsui, SY; Yew, WW | 1 |
Lois, N; Perez del Molino, ML | 1 |
Alvarez, R; Arias, A; Felipe, A; Hernández García, AM; Sierra, A | 1 |
Eckhoff, DG; Pring, M | 1 |
Chang, JS; Huang, SC; Liang, YS; Soong, HK | 1 |
Furukawa, T; Komachi, H; Nagai, R; Saito, Y; Takewaki, S; Uchihara, T | 1 |
Brancato, R; Carones, F; Cavallero, A; Gesu, G; Venturi, E | 1 |
Hu, FR; Luh, KT | 1 |
Clumeck, N; De Wit, S; Payen, MC | 1 |
Athmanathan, S; Garg, P; Rao, GN | 1 |
Böttger, EC; Brown, BA; Frischkorn, K; Onyi, GO; Prammananan, T; Sander, P; Wallace, RJ; Zhang, Y | 1 |
Carton, AT; Kerawala, CJ; Makhani, S; Postlethwaite, KR; Renny, NM | 1 |
Ena, P; Fadda, G; Leigheb, G; Sechi, LA; Zanetti, S | 1 |
Bergmann, JS; Boulet, B; Brown, BA; Fahle, GA; Plaunt, M; Wallace, RJ; Wanger, A; Witebsky, FG; Woods, GL | 1 |
Midani, S; Rathore, MH | 1 |
Adjei, O; Allen, BW; Banerjee, DK; Evans, MR; Portaels, F; Thangaraj, HS; Wansbrough-Jones, MH | 1 |
Bansal, AK; Garg, P; Sharma, S; Vemuganti, GK | 1 |
Cabras, AD; Höfler, H; Kremer, M; Lügering, A; Schulz, S; Seidel, M; Werner, M | 1 |
Culbertson, WW; Dubovy, SR; Huang, AJ; Karp, CL; Miller, D; Solomon, A | 1 |
Giaconi, J; Pham, R; Ta, CN | 1 |
Brahm, M; Bruun, B; Kolmos, HJ | 1 |
Berlin, OG; Bruckner, DA; Holland, GN; Paschal, JF; Phinney, RB; Stevens, RK | 1 |
Bullington, RH; Font, RL; Lanier, JD | 1 |
Singh, N; Yu, VL | 1 |
Gómez-Garcés, JL; Rodriguez-Tudela, JL; Soriano, F; Velo, M | 1 |
Andrzejczyk, Z; Janowiec, M; Marczewska, J | 1 |
Aung-khin, M; Kwan, SY; Ma, WK; Mok, CK; Yew, WW | 1 |
Borrego Galán, JC; Chimpén Ruiz, VA; Mejía Molina, P; Zurdo García, JR | 1 |
Aylward, GW; Marsh, RJ; Stacey, AR | 1 |
Clark, GL; Kleinert, JM; O'Donovan, C; Zachary, LS | 1 |
Arai, H; Kaminaga, Y; Nagai, R; Naito, S; Nakajima, H | 1 |
Hendrick, SJ; Jorizzo, JL; Newton, RC | 1 |
Baird, B; Fauci, AS; Gill, V; Grimes, G; Lane, HC; Masur, H; Tuazon, C | 1 |
Polis, MA; Tuazon, CU | 1 |
Bullen, MG; Silcox, VA; Swenson, JM; Wallace, RJ | 1 |
Carvallo, E; Fenske, NA; Madjar, DD; Proper, SA | 1 |
19 review(s) available for amikacin and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
A clinical case and a review of Mycobacterium fortuitum infections direct diagnosis approach and treatment in a patient with leg fractures.
Topics: Amikacin; Humans; Leg; Mycobacterium fortuitum; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; RNA, Ribosomal, 16S | 2022 |
State-of-the-art treatment strategies for nontuberculous mycobacteria infections.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Practice Guidelines as Topic | 2020 |
The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.
Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Mycobacterium Infections, Nontuberculous; Suspensions | 2020 |
Atypical mycobacterial infections - management and when to treat.
Topics: Amikacin; Animals; Antitubercular Agents; Humans; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tuberculosis | 2021 |
Management of peritoneal dialysis
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Humans; Linezolid; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Peritoneal Dialysis; Peritonitis | 2022 |
Pulmonary Mycobacterium abscessus Infection in an 11-Year-Old Child, Successfully Treated with Inhaled/Parenteral Amikacin: A Case Report and Review of Literature.
Topics: Amikacin; Anti-Bacterial Agents; Child; Clarithromycin; Humans; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2021 |
Treatment of Mycobacterium abscessus Pulmonary Disease.
Topics: Amikacin; Anti-Bacterial Agents; Disease Management; Drug Resistance, Bacterial; Humans; Macrolides; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary | 2022 |
Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction.
Topics: Administration, Ophthalmic; Administration, Oral; Amikacin; Anti-Bacterial Agents; Clarithromycin; Corneal Surgery, Laser; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Microsurgery; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Myopia; Refraction, Ocular; Surgical Flaps; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2018 |
New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.
Topics: Amikacin; Anti-Bacterial Agents; Clofazimine; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Liposomes; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nitroimidazoles; Oxazoles | 2019 |
Topics: Aged; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Databases, Factual; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Debridement; Diagnosis, Differential; Humans; Immunity, Innate; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Skin; Skin Diseases, Bacterial | 2014 |
Mycobacterium abscessus: challenges in diagnosis and treatment.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Cystic Fibrosis; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Genotype; Humans; Molecular Diagnostic Techniques; Molecular Sequence Data; Mycobacterium Infections, Nontuberculous; Polymorphism, Single Nucleotide; Respiratory Tract Infections; Sequence Analysis, DNA; Transcription Factors; Treatment Outcome | 2014 |
Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
Topics: Amikacin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Indicators and Reagents; Keratomileusis, Laser In Situ; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Postoperative Complications; Staining and Labeling; Tobramycin | 2003 |
Breast implant infection with Mycobacterium fortuitum group: report of case and review.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Breast Implants; Ciprofloxacin; Female; Humans; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Prosthesis-Related Infections | 2006 |
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
Topics: Activities of Daily Living; AIDS-Related Opportunistic Infections; Amikacin; Anemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cause of Death; Chemoprevention; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Fever; Granulocyte Colony-Stimulating Factor; Health Status; Humans; Immunocompromised Host; Immunotherapy; Incidence; Interferon-gamma; Molecular Biology; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Tuberculosis; Virulence; Weight Loss | 1997 |
Mycobacterium fortuitum infection of ventriculoperitoneal shunt.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Causality; Central Nervous System Infections; Cross Infection; Debridement; Drainage; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Trimethoprim, Sulfamethoxazole Drug Combination; Ventriculoperitoneal Shunt | 1999 |
Bilateral infectious keratitis after laser in situ keratomileusis: a case report and review of the literature.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cornea; Cyanoacrylates; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Surgical Wound Infection; Visual Acuity | 2001 |
Nontuberculous mycobacterial keratitis. Report of two cases and review of the literature.
Topics: Aged; Amikacin; Corneal Ulcer; Eye Infections, Bacterial; Female; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Scleritis; Visual Acuity | 1992 |
Successful treatment of pulmonary infection due to Mycobacterium chelonae: case report and review.
Topics: Amikacin; Cefoxitin; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Sputum; Tomography, X-Ray Computed | 1992 |
3 trial(s) available for amikacin and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Outpatients; Retrospective Studies; Sputum; Treatment Outcome | 2016 |
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Prospective Studies; Treatment Outcome | 2017 |
Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
Topics: Administration, Topical; Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cornea; Eye Infections, Bacterial; Female; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ophthalmic Solutions; Prospective Studies | 1998 |
176 other study(ies) available for amikacin and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
Curing Mycobacterium ulcerans infection in mice with a combination of rifampin-streptomycin or rifampin-amikacin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome | 2007 |
Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Cells, Cultured; Clarithromycin; Colony Count, Microbial; Host-Pathogen Interactions; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Plankton | 2008 |
[Mycobacterium abscessus, a model of resistance to multiple antibiotic classes].
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2021 |
Life-threatening Mycobacterium intracellulare pleuritis in an immunocompetent host: Case reports.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Ethambutol; Humans; Immunocompromised Host; Male; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pleurisy; Rifampin; Tomography, X-Ray Computed | 2021 |
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2022 |
Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Liposomes; Macrophages; Male; Mice; Mice, Inbred C57BL; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Phagosomes; Phosphatidylinositol Phosphates; Reactive Oxygen Species | 2022 |
Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Retrospective Studies; Treatment Outcome | 2022 |
Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2022 |
Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Humans; Iran; Laboratories; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Tuberculosis | 2022 |
Outcomes of Nontuberculous Mycobacterial Keratitis After Clear Corneal Incision Phacoemulsification Surgery: A Case Series of 6 Eyes in South Florida.
Topics: Abscess; Amikacin; Azithromycin; Clarithromycin; Eye Infections, Bacterial; Florida; Humans; Keratitis; Mycobacterium Infections, Nontuberculous; Phacoemulsification | 2022 |
Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells.
Topics: Amikacin; Anti-Bacterial Agents; Eukaryotic Cells; Humans; Liposomes; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2022 |
Topics: Amikacin; Animals; Anti-Bacterial Agents; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Neutropenia; Nontuberculous Mycobacteria | 2022 |
Characteristics of clinical isolates of nontuberculous mycobacteria in Java-Indonesia: A multicenter study.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Indonesia; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2022 |
In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; United States | 2023 |
Cysteamine/Cystamine Exert Anti-
Topics: Amikacin; Anti-Bacterial Agents; Cystamine; Cysteamine; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2023 |
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium abscessus; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria | 2023 |
MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Macrolides; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Prospective Studies | 2023 |
MarR-Dependent Transcriptional Regulation of
Topics: Amikacin; Anti-Bacterial Agents; Ethionamide; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Mycolic Acids | 2023 |
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin | 2023 |
A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Organizing Pneumonia; Pneumonia | 2023 |
Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Drug Interactions; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2023 |
The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriophages; Delivery of Health Care; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Phylogeny; Tigecycline | 2023 |
Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Clofazimine; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Humans; Leprostatic Agents; Liposomes; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2023 |
Secondary Mycobacterium abscessus Infection after Debridement in Child with Dog Bite: a Case Report.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Debridement; Dogs; Female; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous | 2023 |
Haemophagocytic syndrome caused by disseminated nontuberculous mycobacterial infection.
Topics: Amikacin; Ciprofloxacin; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Mycobacterium Infections, Nontuberculous; Opportunistic Infections | 2023 |
Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand.
Topics: Amikacin; Anti-Infective Agents; Clarithromycin; Humans; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Schools, Medical; Thailand | 2023 |
Aortic endograft infection by Mycobacterium abscessus subsp. massiliense with acquired clarithromycin resistance: a case report.
Topics: Abscess; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Resistance, Bacterial; Humans; Macrolides; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Stents | 2023 |
In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2023 |
Rare case of pacemaker infection with
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Arrhythmias, Cardiac; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Epidural Abscess; Heroin Dependence; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Pacemaker, Artificial; Prosthesis-Related Infections | 2019 |
No Amikacin, No Problem: a Successful Treatment Approach for Pediatric Otomastoiditis Due to Amikacin-Resistant Mycobacterium abscessus.
Topics: Amikacin; Anti-Bacterial Agents; Child; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous | 2020 |
In reply-Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex.
Topics: Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous | 2020 |
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
Topics: Amikacin; Antitubercular Agents; Diarylquinolines; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Macrolides; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Soft Tissue Injuries; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam; Young Adult | 2020 |
Choosing the therapy for neurological infection with rapidly growing mycobacteria.
Topics: Administration, Intravenous; Adolescent; Amikacin; Central Nervous System Bacterial Infections; Clinical Decision-Making; Female; Humans; Imipenem; Levofloxacin; Linezolid; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ventriculoperitoneal Shunt | 2020 |
Evaluation of the GenoType NTM-DR assay performance for the identification and molecular detection of antibiotic resistance in Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Polymerase Chain Reaction; Reagent Kits, Diagnostic | 2020 |
The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Drug Synergism; Female; Humans; Imipenem; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2020 |
Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2021 |
Clinical and demographic study of non-tuberculous mycobacterial ocular infections in South India.
Topics: Amikacin; Anti-Bacterial Agents; Biocompatible Materials; Eye Infections; Humans; India; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Phylogeny; Retrospective Studies | 2021 |
Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
Topics: Administration, Inhalation; Aged; Amikacin; Anti-Bacterial Agents; Azithromycin; Clofazimine; Drug Therapy, Combination; Female; Humans; Imipenem; Lung Diseases; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Prospective Studies | 2021 |
Pneumonia due to
Topics: Aged; Amikacin; Clarithromycin; Humans; Kidney Transplantation; Male; Mycobacteriaceae; Mycobacterium Infections, Nontuberculous | 2021 |
Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Humans; India; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin | 2021 |
Rapid macrolide and amikacin resistance testing for
Topics: Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Drug Resistance, Bacterial; Environmental Microbiology; Humans; Macrolides; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Respiratory System | 2021 |
Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Japan; Linezolid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2021 |
Radiographic severity and treatment outcome of Mycobacterium abscessus complex pulmonary disease.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Radiography, Thoracic; Retrospective Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Clinical Whole Genome Sequencing for Clarithromycin and Amikacin Resistance Prediction and Subspecies Identification of Mycobacterium abscessus.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Clinical Laboratory Techniques; Drug Resistance, Multiple, Bacterial; Humans; Laboratories, Clinical; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Phylogeny; Polymorphism, Single Nucleotide; Prognosis; RNA, Ribosomal, 16S; Whole Genome Sequencing | 2021 |
Once-daily dosing of amikacin for treatment of
Topics: Aged; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Monitoring; Female; Hearing Loss; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Republic of Korea; Retrospective Studies; Tinnitus | 2017 |
Examining the Effect of Residual Amikacin on Sputum Culture for Nontuberculous Mycobacteria.
Topics: Administration, Inhalation; Amikacin; Culture Media; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sensitivity and Specificity; Sputum | 2018 |
The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.
Topics: Administration, Inhalation; Aged; Amikacin; Cough; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Mycobacterium; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Retrospective Studies; Sputum; Thorax; Treatment Outcome | 2017 |
Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Antagonism; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2017 |
Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Chlorocebus aethiops; Disease Models, Animal; Drug Discovery; Kinetics; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Onium Compounds; Small Molecule Libraries; Thienamycins; Vero Cells | 2017 |
In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; DNA-Directed RNA Polymerases; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2018 |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; High-Throughput Nucleotide Sequencing; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Taiwan; Tertiary Care Centers; Tigecycline | 2017 |
Curcumin, an antibiotic resistance breaker against a multiresistant clinical isolate of Mycobacterium abscessus.
Topics: Amikacin; Curcumin; Humans; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2018 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.
Topics: Amikacin; Animals; Larva; Levofloxacin; Linezolid; Meropenem; Moths; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2018 |
Antimicrobial activity against Mycobacterium tuberculosis under in vitro lipid-rich dormancy conditions.
Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Drug Tolerance; Fluoroquinolones; Genetic Fitness; Genotype; Humans; Lipid Metabolism; Lipids; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Rifampin | 2018 |
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Azithromycin; Drug Resistance, Multiple, Bacterial; Hip Joint; Humans; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tigecycline | 2018 |
Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Clarithromycin; Female; Fluoroquinolones; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Reunion | 2018 |
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child.
Topics: Amikacin; Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Humans; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Otitis Media; Tigecycline; Tokyo | 2018 |
Mycobacterium abscessus Infection During Ustekinumab Treatment in Crohn's Disease: A Case Report and Review of the Literature.
Topics: Amikacin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Cefoxitin; Crohn Disease; Drug Administration Schedule; Female; Humans; Ileal Diseases; Injections, Subcutaneous; Interleukin-12 Subunit p40; Magnetic Resonance Imaging; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Thigh; Treatment Outcome; Ustekinumab | 2018 |
Genetic Correlation of Antibiotic Susceptibility and Resistance Genotyping for the
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Sequence Analysis, DNA; Thailand | 2018 |
Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency.
Topics: Adrenal Insufficiency; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Male; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Sputum | 2019 |
Postoperative Mycobacteroides abscessus subsp. abscessus endophthalmitis: Clinical analysis of 12 clustered adults and a proposed therapeutic algorithm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; Clarithromycin; Endophthalmitis; Eye; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Taiwan; Vitrectomy; Young Adult | 2020 |
Topics: Adult; Amikacin; Anti-Bacterial Agents; Catheter-Related Infections; Cerebrospinal Fluid Shunts; Device Removal; Female; Humans; Imipenem; Immunocompetence; Meningitis, Bacterial; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Pseudotumor Cerebri | 2019 |
Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada.
Topics: Administration, Intravenous; Adult; Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Ontario; Ototoxicity; Retrospective Studies; Sputum; Treatment Outcome | 2019 |
Mycobacterium abscessus urinary tract infection: case report.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Treatment Outcome; Urinary Tract Infections | 2020 |
Successful management of severe post-LASIK Mycobacterium abscessus keratitis with topical amikacin and linezolid, flap ablation, and topical corticosteroids.
Topics: Ablation Techniques; Administration, Topical; Adult; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Keratitis; Keratomileusis, Laser In Situ; Linezolid; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Surgical Flaps; Surgical Wound Infection | 2019 |
Crystal structure of the aminoglycosides N-acetyltransferase Eis2 from Mycobacterium abscessus.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Crystallography, X-Ray; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Protein Conformation | 2019 |
Mycobacterium abscessus complex lung infection in a toddler with a tracheostomy.
Topics: Amikacin; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Child, Preschool; Clarithromycin; Female; Humans; Laryngostenosis; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline; Tomography, X-Ray Computed; Tracheostomy; Tuberculosis, Pulmonary | 2014 |
Dual infection by streptococcus and atypical mycobacteria following Ahmed glaucoma valve surgery.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefazolin; Conjunctiva; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glaucoma; Glaucoma Drainage Implants; Humans; Male; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Necrosis; Pneumococcal Infections; Postoperative Complications; Streptococcus pneumoniae; Vitreous Body | 2013 |
Mab_3168c, a putative acetyltransferase, enhances adherence, intracellular survival and antimicrobial resistance of Mycobacterium abscessus.
Topics: Acetyltransferases; Amikacin; Anti-Infective Agents; Biofilms; Computational Biology; Drug Resistance, Microbial; Hydrophobic and Hydrophilic Interactions; Macrophages; Muramidase; Mutation; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Promoter Regions, Genetic | 2013 |
Post-operative sinus formation due to Mycobacterium abscessus: a case report.
Topics: Adult; Amikacin; Antitubercular Agents; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Clarithromycin; Female; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Surgical Wound Infection; Treatment Outcome | 2013 |
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Culture Media; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Sensitivity and Specificity; Tobramycin | 2013 |
Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.
Topics: Administration, Inhalation; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Female; Humans; Kartagener Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
A cluster of endophthalmitis caused by Mycobacterium abscessus after cataract surgery.
Topics: Adolescent; Aged; Amikacin; Betamethasone; Cataract; Electrophoresis, Gel, Pulsed-Field; Endophthalmitis; Eye; Female; Humans; Male; Methyltransferases; Middle Aged; Molecular Typing; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ophthalmologic Surgical Procedures; Polymerase Chain Reaction; Postoperative Complications; Taiwan; Vitrectomy | 2016 |
[Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia].
Topics: Amikacin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Humans; Imipenem; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Levofloxacin; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Prednisolone; Treatment Outcome | 2014 |
Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection.
Topics: Administration, Inhalation; Aerosols; Amikacin; Animals; Antitubercular Agents; Cell Line; Colony Count, Microbial; Disease Models, Animal; Drug Delivery Systems; Drug Resistance, Bacterial; Female; Humans; Intracellular Space; Liposomes; Lung; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections | 2014 |
Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Young Adult | 2015 |
Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
Topics: Administration, Topical; Aged; Amikacin; Anti-Bacterial Agents; Azepines; Clarithromycin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Retrospective Studies; Topoisomerase II Inhibitors; Visual Acuity | 2015 |
Inhaled Antibiotics for Refractory Nontuberculous Mycobacteria and Non-Cystic Fibrosis Bronchiectasis and the Significance of Mycobacterium abscessus subsp. abscessus Isolation during M. avium Complex Lung Disease Therapy.
Topics: Amikacin; Anti-Bacterial Agents; Female; Humans; Male; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary | 2015 |
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION SUCCESSFULLY TREATED WITH SHORT-TERM CAM, AMK, AND IPM/cs FOLLOWED BY LONG-TERM ORAL CAM AND LVFX].
Topics: Administration, Oral; Aged; Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Female; Humans; Imipenem; Levofloxacin; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2015 |
Pulmonary Mycobacterium abscessus Infection in a Patient with Triple A Syndrome.
Topics: Adrenal Insufficiency; Amikacin; Anti-Bacterial Agents; Child; Clarithromycin; Esophageal Achalasia; Humans; Imipenem; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Outcome | 2016 |
Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Therapy, Combination; Female; Humans; Imipenem; Macrolides; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Prospective Studies; Sputum; Treatment Outcome | 2016 |
Mycobacterium chelonae Scleral Abscess After Intravitreal Ranibizumab Injection.
Topics: Abscess; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Clarithromycin; Diabetic Retinopathy; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ranibizumab; Scleral Diseases; Vascular Endothelial Growth Factor A | 2016 |
Necrotizing Thrombophlebitis Secondary to Mycobacterium Chelonae in a Hemodialyzed Patient.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Humans; Immunohistochemistry; Kidney Failure, Chronic; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Necrosis; Prognosis; Renal Dialysis; Severity of Illness Index; Thrombophlebitis; Treatment Outcome | 2017 |
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Failure | 2016 |
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Thrombocytopenia; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
Topics: Amikacin; Anti-Bacterial Agents; Clofazimine; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections, Nontuberculous | 2010 |
[Three cases of panniculitis due to Mycobacterium abscessus after mesotherapy].
Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Cosmetic Techniques; Disease Outbreaks; Drainage; Female; Humans; Injections, Intradermal; Materia Medica; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Opportunistic Infections; Panniculitis; Skin Ulcer; Spain; Tuberculoma; Wound Infection | 2010 |
Bilateral parotitis caused by Mycobacterium chelonae in an immunocompetent child.
Topics: Amikacin; Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Debridement; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Parotid Gland; Parotitis | 2009 |
Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis.
Topics: Administration, Oral; Administration, Topical; Amikacin; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Young Adult | 2010 |
Targeted delivery of amikacin into granuloma.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cells, Cultured; Disease Models, Animal; Drug Delivery Systems; Granuloma; Mice; Microscopy, Fluorescence; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Neoplasms, Experimental | 2010 |
Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
Topics: Amikacin; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Methylene Blue; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Photochemotherapy; Quinolines; Rabbits | 2011 |
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Topics: Amikacin; Antibiotics, Antitubercular; Cefoxitin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome | 2011 |
Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Treatment Outcome | 2010 |
[Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Lung Diseases; Middle Aged; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline | 2011 |
[Pleuropneumonia due to Mycobacterium chelonae].
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Clarithromycin; Drainage; Drug Therapy, Combination; Humans; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Pleuropneumonia; Risk Factors; Treatment Outcome | 2011 |
Bone marrow infection with Mycobacterium fortuitum in a diabetic patient.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bone Marrow; Bone Marrow Diseases; Ciprofloxacin; Diabetes Mellitus, Type 2; Humans; Isoniazid; Male; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome | 2011 |
Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Aza Compounds; Child; Child, Preschool; Clarithromycin; Combined Modality Therapy; Corneal Ulcer; Eye Infections, Bacterial; Female; Florida; Fluoroquinolones; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ophthalmologic Surgical Procedures; Quinolines; Retrospective Studies; Risk Factors; Surgical Wound Infection; Young Adult | 2012 |
A trojan horse strategy to deliver amikacin to mycobacterial granulomas.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Granuloma; Mycobacterium Infections, Nontuberculous | 2011 |
Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.
Topics: Aerosols; Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Treatment Outcome | 2012 |
Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.
Topics: Amikacin; Anti-Infective Agents; Clarithromycin; Computer Simulation; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Models, Biological; Models, Theoretical; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Tuberculosis | 2012 |
Lung abscess due to non-tuberculous, non-Mycobacterium fortuitum in a neonate.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Infant, Newborn; Lung Abscess; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Radiography; Treatment Outcome | 2012 |
Periprosthetic atypical mycobacterial infection in breast implants: a new kid on the block!
Topics: Acetamides; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Breast Implants; Clarithromycin; Female; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Mammaplasty; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Reoperation | 2013 |
Successful treatment of refractory cutaneous infection caused by Mycobacterium marinum with a combined regimen containing amikacin.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Chaperonin 60; Genotype; Humans; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 16S | 2012 |
Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Taiwan; Tigecycline | 2013 |
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Skin Ulcer | 2002 |
Mycobacterium chelonae keratitis associated with soft contact lens wear.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Contact Lenses, Hydrophilic; Humans; Keratitis; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Visual Acuity | 2002 |
In vitro sensitivity of Mycobacterium xenopi to five antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Ofloxacin; Rifampin | 2002 |
Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Child; Clarithromycin; Cohort Studies; Cystic Fibrosis; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Retrospective Studies; Rifampin; Streptomycin | 2003 |
[A case of lung infection due to Mycobacterium abscessus].
Topics: Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Radiography; Sputum; Tuberculosis, Pulmonary | 2003 |
Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin.
Topics: Amikacin; Animals; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Time Factors | 2003 |
[Treatment and a follow-up study on wound infection by Mycobacterium chelonae: report of 168 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Surgical Wound Infection | 2004 |
Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Topics: Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits | 2004 |
[A case of bronchial ulcer due to infection by Mycobacterium abscessus].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bronchial Diseases; Bronchitis; Cefoxitin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tracheitis; Ulcer | 2004 |
Mycobacterium chelonae wound ulcer after clear-cornea cataract surgery.
Topics: Aged; Aged, 80 and over; Amikacin; Cataract Extraction; Clarithromycin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Surgical Wound Infection | 2004 |
Mycobacterium keratitis after laser in situ keratomileusis.
Topics: Administration, Topical; Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cornea; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Keratitis; Keratomileusis, Laser In Situ; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Reoperation; Retrospective Studies; Surgical Wound Infection; Treatment Outcome | 2005 |
Mycobacterium chelonae keratitis: elucidation of diagnosis through evaluation of smears of fluid from patient's contact lens care system.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Contact Lens Solutions; Contact Lenses; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Humans; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Treatment Outcome | 2005 |
Osteomyelitis of the mandible due to Mycobacterium abscessus: a case report.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Mandibular Diseases; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Rifampin; Root Canal Therapy | 2005 |
An esophageal mass with coexistent Mycobacterium chelonae and Candida albicans infections in an immunocompetent adult.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Fluconazole; Humans; Imipenem; Immunocompetence; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 2006 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
Iatrogenic Mycobacterium abscessus infection associated with acupuncture: clinical manifestations and its treatment.
Topics: Acupuncture Therapy; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Iatrogenic Disease; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Time Factors; Treatment Outcome | 2005 |
Mycobacterium xenopi multiplies within human macrophages and enhances HIV replication in vitro.
Topics: AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; gag Gene Products, Human Immunodeficiency Virus; Gene Products, gag; HIV Infections; HIV-1; Humans; Macrophages; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Virus Activation; Virus Replication | 2006 |
Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone.
Topics: Adult; Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Clarithromycin; Corneal Stroma; Debridement; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Postoperative Complications; Surgical Flaps | 2006 |
In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans.
Topics: Acetamides; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Diarylquinolines; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Foot; In Vitro Techniques; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Nitroimidazoles; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Survival Analysis; Time Factors | 2006 |
Mycobacterium abscessus endophthalmitis: treatment dilemma and review of the literature.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Device Removal; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Lens Implantation, Intraocular; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Phacoemulsification; Postoperative Complications; Vitrectomy; Vitreous Body | 2006 |
[A case of Mycobacterium abscessus pulmonary infection; effectiveness of clarithromycin, amikacin and imipenem/cilastatin].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography, Thoracic; Tuberculosis, Pulmonary | 2006 |
Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
Topics: Adult; Amikacin; Anti-Infective Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines | 2007 |
[Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation].
Topics: Amikacin; Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Cord Blood Stem Cell Transplantation; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Lymphohistiocytosis, Hemophagocytic; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Treatment Outcome | 2008 |
Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.
Topics: Adult; Amikacin; Cefoxitin; Drug Resistance, Microbial; Granulocytes; Humans; Kanamycin; Lymphoma; Male; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Skin Diseases, Infectious | 1984 |
Mycobacterium chelonei keratitis: a case report.
Topics: Aged; Amikacin; Cornea; Corneal Ulcer; Female; Humans; Kanamycin; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous | 1983 |
Mycobacterium fortuitum pulmonary infection associated with an antigen-selective defect in cellular immunity.
Topics: Amikacin; Cell Migration Inhibition; Immunity, Cellular; Leukocyte Migration-Inhibitory Factors; Mycobacterium Infections, Nontuberculous; T-Lymphocytes; Tuberculosis, Pulmonary | 1981 |
Mycobacterium chelonei keratitis.
Topics: Adult; Amikacin; Corneal Ulcer; Eye Foreign Bodies; Humans; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 1982 |
Atypical mycobacteria periprosthetic infections--diagnosis and treatment.
Topics: Amikacin; Breast; Curettage; Doxycycline; Drug Therapy, Combination; Ethambutol; Female; Humans; Mastitis; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Pregnancy; Prostheses and Implants; Surgery, Plastic; Surgical Wound Infection | 1980 |
Atypical mycobacterial cervical lymphadenitis--treatment with surgery and antibiotics.
Topics: Amikacin; Child, Preschool; Female; Humans; Infant; Lymphadenitis; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Neck; Retrospective Studies | 1981 |
Mycobacterium chelonei septicemia in a premature infant.
Topics: Amikacin; Erythromycin; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis | 1980 |
Atypical Mycobacterium and breast surgery.
Topics: Adult; Amikacin; Clarithromycin; Female; Humans; Imipenem; Mammaplasty; Mycobacterium Infections, Nontuberculous; Surgical Wound Infection | 1995 |
Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates.
Topics: Amikacin; Anti-Bacterial Agents; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 1994 |
Treatment of Mycobacterium chelonae keratitis with amikacin, doxycycline and topical ciprofloxacin.
Topics: Administration, Topical; Amikacin; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 1994 |
Rifampin-resistant Mycobacterium kansasii.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Ciprofloxacin; Clinical Protocols; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Texas; Treatment Outcome; Tuberculosis | 1994 |
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
Topics: Administration, Topical; Amikacin; Animals; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Male; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits; Vancomycin | 1993 |
Combination drug testing of Mycobacterium chelonae.
Topics: Amikacin; Corneal Ulcer; Drug Synergism; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 1993 |
Ciprofloxacin therapy of Mycobacterium chelonae keratitis.
Topics: Amikacin; Ciprofloxacin; Female; Humans; Keratitis; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 1993 |
Retroperitoneal abscess caused by Mycobacterium chelonae and treatment.
Topics: Abscess; Adult; Amikacin; Cefazolin; Drug Therapy, Combination; Hospitals, Community; Hospitals, Teaching; Humans; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Retroperitoneal Space; Trimethoprim, Sulfamethoxazole Drug Combination; Wounds, Gunshot | 1993 |
A cluster of four cases of Mycobacterium haemophilum infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Antitubercular Agents; Bone Marrow Transplantation; Ciprofloxacin; Cluster Analysis; Doxycycline; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 1993 |
Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.
Topics: Amikacin; Colony Count, Microbial; Culture Media; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin | 1993 |
Mycobacterium chelonae keratitis: resolution after debridement and presoaked collagen shields.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Collagen; Combined Modality Therapy; Cornea; Corneal Injuries; Debridement; Drug Delivery Systems; Eye Foreign Bodies; Eye Infections, Bacterial; Eye Injuries; Humans; Keratitis; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Wounds, Nonpenetrating | 1995 |
[In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Humans; Lactams; Macrolides; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Water Microbiology | 1995 |
Mycobacterium chelonae infection following a total knee arthroplasty.
Topics: Aged; Amikacin; Cefoxitin; Drug Therapy, Combination; False Negative Reactions; Female; Humans; Knee Prosthesis; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prosthesis-Related Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Non-tuberculous mycobacterial keratitis: a study of 22 cases.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Eye Injuries; Female; Follow-Up Studies; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Retrospective Studies; Rifampin; Treatment Outcome; Visual Acuity | 1996 |
Successful treatment of atypical mycobacterial meningitis by fluoroquinolone.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Ethambutol; Humans; Injections, Spinal; Isoniazid; Male; Meningitis; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Ofloxacin; Polymerase Chain Reaction; Rifampin; Streptomycin | 1996 |
Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Follow-Up Studies; Humans; Lasers, Excimer; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Photorefractive Keratectomy; Postoperative Complications; Visual Acuity; Wound Healing | 1997 |
Mycobacterium chelonei masquerading as Corynebacterium in a case of infectious keratitis: a diagnostic dilemma.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cornea; Corynebacterium; Corynebacterium Infections; Diagnosis, Differential; Eye Infections, Bacterial; Humans; Keratitis; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions | 1998 |
A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae.
Topics: Alleles; Amikacin; Anti-Bacterial Agents; DNA Mutational Analysis; DNA, Ribosomal; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Hexosamines; Humans; Microbial Sensitivity Tests; Mutagenesis; Mycobacterium chelonae; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nucleic Acid Conformation; Random Amplified Polymorphic DNA Technique; RNA, Ribosomal, 16S | 1998 |
Atypical cervico-facial mycobacterial infections in childhood.
Topics: Algorithms; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Drug Combinations; Face; Female; Humans; Lymph Node Excision; Lymphadenitis; Mycobacterium Infections, Nontuberculous; Neck; Nontuberculous Mycobacteria; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
The use of amikacin in the treatment of primary cutaneous mycobacteriosis due to Mycobacterium fortuitum.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Female; Humans; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial | 1999 |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Culture Media; Doxycycline; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Tobramycin | 1999 |
In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Humans; Leprostatic Agents; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Uganda | 2000 |
Molecular diagnosis of a Mycobacterium chelonae infection.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Female; Humans; Imipenem; Lymph Nodes; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Polymerase Chain Reaction | 2001 |
Mycobacterium interface keratitis after laser in situ keratomileusis.
Topics: Adult; Amikacin; Clarithromycin; Cornea; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Time Factors | 2001 |
Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis.
Topics: Adult; Amikacin; Clarithromycin; Corneal Stroma; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Surgical Flaps; Visual Acuity | 2002 |
Peritonitis with Mycobacterium fortuitum in a patient on continuous ambulatory peritoneal dialysis.
Topics: Adult; Amikacin; Humans; Kidney Transplantation; Male; Mycobacterium Infections, Nontuberculous; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Postoperative Complications; Staphylococcal Infections | 1992 |
Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
Topics: Amikacin; Animals; Ciprofloxacin; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ophthalmic Solutions; Rabbits; Random Allocation | 1992 |
Two possibly related cases of Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.
Topics: Adult; Amikacin; Cross Infection; Doxycycline; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1989 |
[Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Gentamicins; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Species Specificity | 1989 |
Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection.
Topics: Adult; Aged; Amikacin; Cardiac Surgical Procedures; Drug Combinations; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Sternum; Surgical Wound Infection | 1989 |
[Pneumonia caused by Mycobacterium chelonei. Apropos of a case].
Topics: Aged; Aged, 80 and over; Amikacin; Cefotaxime; Female; Humans; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Pneumonia | 1988 |
Mycobacterium chelonei infection of a corneal graft.
Topics: Amikacin; Contact Lenses, Hydrophilic; Corneal Transplantation; Corneal Ulcer; Female; Humans; Keratitis; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Postoperative Complications | 1987 |
Mycobacterium chelonei tenosynovitis.
Topics: Amikacin; Carpal Tunnel Syndrome; Combined Modality Therapy; Female; Humans; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tenosynovitis | 1988 |
Amikacin treatment for Mycobacterium marinum infection.
Topics: Aged; Amikacin; Granuloma; Humans; Injections, Intramuscular; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous | 1986 |
Giant Mycobacterium fortuitum abscess associated with systemic lupus erythematosus.
Topics: Abscess; Adult; Amikacin; Doxycycline; Drainage; Female; Humans; Lupus Erythematosus, Systemic; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Skin Diseases, Infectious | 1986 |
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Cycloserine; Drug Therapy, Combination; Humans; Isoniazid; Lactams, Macrocyclic; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis | 1987 |
Clues to the early diagnosis of Mycobacterium avium-intracellulare infection in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Anti-Bacterial Agents; Clofazimine; Female; Humans; Lactams, Macrocyclic; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis | 1985 |
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Combinations; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Sulfisoxazole; Sulfonamides; Tetracyclines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Adjunctive surgical management of cutaneous Mycobacterium fortuitum infection.
Topics: Administration, Oral; Amikacin; Diabetes Mellitus, Type 1; Humans; Injections, Intramuscular; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Silver Sulfadiazine; Skin Diseases; Sulfamethizole; Surgery, Plastic | 1985 |